LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
ISPC iSpecimen
- 1.660
- +0.050+3.11%
Close Feb 28 16:00 ET
- 1.650
- -0.010-0.60%
Post 20:01 ET
1.60MMarket Cap-0.09P/E (TTM)
1.670High1.540Low96.08KVolume1.590Open1.610Pre Close150.53KTurnover11.29%Turnover RatioLossP/E (Static)962.64KShares11.80052wk High0.34P/B1.41MFloat Cap1.54052wk Low--Dividend TTM850.83KShs Float579.598Historical High--Div YieldTTM8.07%Amplitude1.540Historical Low1.566Avg Price1Lot Size
About iSpecimen Company
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.
Company Profile
SymbolISPC
Company NameiSpecimen
Listing DateJun 17, 2021
Issue Price8.00
Founded2009
CEOMr. Robert Bradley Lim
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address8 Cabot Road,Suite 1800
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-301-6700
Websitehttp://www.ispecimen.com
Company Executives
- Name
- Position
- Salary
- Robert Bradley Lim
- Director, Chief Executive Officer, Treasurer and Secretary
- --
- Yuying Liang
- Chief Financial Officer
- --
- Richard Paolone
- Chairman of the Board
- --
- Katharyn Field
- President
- --
- Siyun Yang
- Independent Director
- --
- George Scholl
- Independent Director
- --
- Avtar Dhaliwal
- Independent Director
- --
- John L. Brooks, III
- Independent Director
- 34.93K
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call